Immortalis exists to end needless human suffering through bold innovation and usher in a new golden age for humanity through Freedom Zones—new jurisdictions engineered to fast-track innovation in longevity, biotech, governance, and frontier technology.
Our first battleground is biotech: we’re engineering a future where no family has to be torn apart by cruel, so-called "incurable" diseases like heart disease, cancer, and Alzheimer's... a future where vitality is the norm, and aging is optional.
We’re creating free environments where visionary scientists and breakthrough thinkers can finally move rapidly to tackle the root causes of chronic illness, age-related decline, and premature death—so precious life can be lived to its fullest extent, not merely survived.
Freedom Zones create a fast lane for life-saving progress where science moves at the speed of human potential—not the speed of bureaucracy. For the first time in history, humanity can live longer, freer, and more powerfully—unbound by genetic fate or ticking clocks.
Love, happiness, and prosperity are limitless. We are building the environments where these honest values can flourish—freely without interference or limit.
From world-renowned scientists and biotech CEOs to investors, policy leaders, and everyday visionaries—over 2,000+ people from all walks of life are uniting behind the movement to accelerate life-saving innovation.
Chairman, U.S. Transhumanist Party • Author of Death Is Wrong
Hear directly from the scientists, founders, investors, and pioneers leading the charge to cure disease, extend life, and transform the future of healthcare.
Millions are dying, trillions are wasted, and global economies are at risk—not because we lack the cures, but because outdated systems are blocking them.
Neovia is our flagship Freedom Zone in the U.S., dedicated to biomedical innovation. Learn more about how Neovia is setting the stage for a healthier future.
Join a community of over 2,000 members from over 40 countries worldwide, united by a shared purpose: to advance humanity into a new era of prosperity and health. Be part of one of the most important missions of mankind.
And How Immortalis Breaks Them
Life-saving therapies are trapped in 10-year pipelines.
Immortalis unlocks them with Freedom Zones—regulatory sandboxes where science moves at the speed of discovery, not bureaucracy.
From 15 years to 2. That’s how we save lives faster.
When progress is slow, capital stays on the sidelines.
Immortalis changes the equation:
Each dollar becomes 10x more efficient
Investors see fast ROI
Billions in biotech funding flood in
This is the dam-break moment for capital into cures
People don’t rally behind theories. They rally behind visible, rapid breakthroughs.
Immortalis delivers results in real time—turning scientists into heroes and igniting global demand for longevity.
When families see lives saved, the world unites.
Immortalis clears the path for rapid cures, serious investment, and unstoppable public momentum.
This is how we end unnecessary suffering—at scale.
DECLARATION OF IMMORTALIS
When freedom reigns, human potential is unleashed.
As a free people, we are solving humanity's greatest challenges. Crime, poverty, diseases – even aging and death will be cured.
Welcome to Immortalis.
A country is forming where all citizens will live with abundance… where all citizens will live with superior health… where all citizens will live in peace, free of crime.
A utopian novel?
No, it is forming as you read this.
Over the past half century, this new country has been idealized in the Neothink Books read by two million people.
Today, this new country has entered the planned, first phase of being actualized as the digital country, Immortalis.
The 10-year plan is to attract enough citizens and wealth in this digital country to proceed in the future with a land purchase with eventual sovereignty…
The man behind this is Mark Hamilton, author of the Neothink Books for the past 45 years. He has dedicated his life to this vision. The idea behind all this is a new constitution named The Prime Law.
The Prime Law simply prohibits initiatory force in civilization, including in government itself. Only self-defense force is allowed.
In short, Mr. Hamilton demonstrates how under the Prime Law Constitution society would take off without political and bureaucratic forces holding back progress. The prosperity of society would rise to such a degree that ordinary citizens would all live prosperous lives as costs fall to fractions during a Great Technological Revolution.
Moreover, that same phenomenon would boost the medical industry so the citizens would all live with superior health breakthroughs at cheaper and cheaper costs. Indeed, the new country would become the medical mecca of the world.
And with the entire point of the Prime Law Constitution being the elimination of initiatory force everywhere, crime would fall to fractions… particularly when would-be criminals are living wealthy lives without committing crime!
Become a pre-citizen of the Immortalis, the founding of a new country, and join our community. It’s free.
Take the first step toward a prosperous and safe life. Become a member today and help build a world where death is not inevitable.
Immortalis is dedicated to creating a prosperous society shielded by the Prime Law for guaranteed safety, abundance, and health, ultimately eradicating aging and death. By removing forced-back regulations, we aim to liberate individuals and boost business and scientific growth for swift life-extending discoveries. Join our mission for a future where eternal life is a choice for all.
The Prime Law is based on the principle that individuals are free to act as they choose, provided they do not harm another person's self, property, or contract. By prohibiting the initiation of force, even by the government itself, the Prime Law establishes a new paradigm of governance.
As the constitution of Immortalis, it guarantees the unobstructed pursuit of happiness and innovation, fostering a society of peace and prosperity for all. Learn about the Prime Law's role in ensuring permanent freedom and integrity for our citizens.
Are you ready to be part of something extraordinary? Become a member of Immortalis and help build a world where freedom, abundance, and longevity are permanent. By joining us, you’ll gain access to a community dedicated to these principles and contribute to a future where death is optional.
Join our community filled with like-minded individuals who value life, freedom, and value-creation. Benefit from discussions, learn from mentors, and contribute to the growth of Immortalis. Your journey to prosperity and eternal life starts here.
5000 Members
Take the first step toward a happier and longer life. Become a member today and help build a world where death is no longer inevitable.
Share your insights and skills to help advance our mission. Your involvement is key to building a prosperous and free society.
The experience behind Immortalis.
Economist, investor, renown author, and builder the word's #1 self-publishing empire. For over 45 years, Mark has developed alternative governance systems and advised global freedom movements, specializing in parallel frameworks that remove bureaucratic friction and unlock human progress. Today, he brings that expertise to the biomedical field—partnering with world-class scientists, companies, and policymakers to build deregulated innovation zones that fast-track breakthrough therapies and extend human life. With Neovia as the flagship, he is building a new class of parallel societies around the world, uniting elite thinkers, companies, and governments to pioneer a parallel system—one built for speed, freedom, and human flourishing.
Entrepreneur, strategist, speaker, and a driving force behind Immortalis—the launchpad for a new era of governance and innovation. Wallace co-develops next-tier regulatory and societal frameworks alongside Mark, designed to accelerate breakthroughs in biotech, AI, energy, and frontier technologies. As both visionary and builder, Wallace drives the execution—leading the ground-up buildout of systems, cities, alliances and structures that bring this new era to life, while rallying over 2,500 supporters behind the mission.
A leading expert on special economic zones and founder of the League of Free Cities—a global partnership and network that has collectively influenced most of the major special zone projects of the 21st century, advising on zones which have taken in over $5 billion in FDI worldwide. Art specializes in building high-trust relationships between governments and private industry to fast-track innovation. His expertise ensures Immortalis delivers what top biotech companies care about most: speed, certainty, and infrastructure built for breakthrough science.
Futurist, economist, and MIT-trained engineer. Founding faculty at Singularity University, fellow of the World Academy of Art & Science and co-author of The Death of Death, championing the end of aging through biotechnology. Director at The Millennium Project and founder of the International Longevity Summit, José advises governments, research institutions, and investors on breakthrough innovation and the future of human longevity. He has been Spanish candidate to the European Parliament.
Architect of Estonia’s digital government and creator of the world’s first e-Residency program. As Estonia’s former CIO, his innovations in digital governance have been adopted globally and are now studied by leading institutions. At Immortalis, Taavi and his famous team will lead the design of streamlined regulatory and compliance systems to support biotech innovation at scale.
Entrepreneur and global ambassador for Immortalis, Cody builds high-trust relationships with industry leaders, policymakers, and scientists to advance our mission. With deep roots in the longevity space and a proven ability to turn connections into strategic partnerships, he represents Immortalis at key events and ensures the right stakeholders are aligned to move innovation forward.
Founder & Chief Science Officer, LEV Foundation | Global Leader in Reversing Aging
Dr. Aubrey de Grey is one of the world’s foremost voices in longevity science and biomedical aging reversal. As Founder and Chief Science Officer of the LEV Foundation, he leads cutting-edge research focused on repairing the molecular and cellular damage that drives aging and age-related diseases.
Trained at the University of Cambridge, where he earned a Ph.D. in biology and a BA in computer science, Dr. de Grey has dedicated his career to mapping every known hallmark of aging—and designing interventions to prevent or reverse them. He is a Fellow of both the Gerontological Society of America and the American Aging Association, and serves on the advisory boards of leading journals and biotech initiatives.
Known for his bold vision that aging is a disease we can—and must—cure, Dr. de Grey is a globally sought-after speaker and tireless advocate for life extension. His leadership has inspired an entire generation of longevity researchers, and his partnership with Immortalis furthers our mission to end unnecessary death and suffering.
Chairman, European Wellness Biomedical Group | Global Pioneer in Regenerative Medicine & Stem Cell Therapy
Prof. Dr. Mike Chan is a globally recognized pioneer in stem cell science, regenerative medicine, and biological anti-aging therapies. As the Co-Founder and Chairman of European Wellness Biomedical Group (Germany), he leads a multinational biotech empire spanning over 80 countries, with R&D, manufacturing, and over 40 medical wellness centers across Europe and Asia.
With over 40 years in the field, Dr. Chan has authored 60+ scientific books, published 100+ papers, and holds 40+ international patents in stem cell, peptide, immunology, and biopharmaceutical technologies. He was one of the first scientists to introduce stem cell therapy to Asia in the 1980s and has since educated thousands of physicians worldwide through over 1,000 global lectures and symposiums.
He serves on the boards of major international scientific bodies, including as Head of the Scientific Committee for ESAAM (Europe’s largest anti-aging medical association), and collaborates with elite institutions like MIT, Oxford, and Heidelberg University. Honored with more than 17 international awards and featured on 30+ magazine covers, Dr. Chan is a visionary leader accelerating the global future of regenerative medicine—and a proud founding supporter of Immortalis.
Chief Scientific Officer, 21st Century Medicine | Pioneering Aging Reversal & Cryopreservation Expert
Dr. Greg Fahy is a world-renowned biogerontologist, cryobiologist, and longevity pioneer best known for leading the groundbreaking TRIIM trial—the first human study to demonstrate regeneration of the thymus and biological age reversal. He holds multiple patents related to thymus regeneration and has been a Fellow and longtime Director of the American Aging Association.
As Chief Scientific Officer of 21st Century Medicine, Dr. Fahy has led revolutionary advancements in organ cryopreservation, including the first successful transplantation of a kidney preserved at -130°C and the co-winning of both the Small and Large Mammal Brain Preservation Prizes.
A lifelong explorer of human longevity, Dr. Fahy edited The Future of Aging: Pathways to Human Life Extension, a foundational text in the field. His current research, based at Stanford University, focuses on reversing immune system aging—one of the leading causes of death in older adults. He brings to Immortalis decades of visionary science and a bold mission: to make aging optional.
Founder & CEO, BioViva Sciences | Pioneer of Gene Therapy & Human Longevity
Elizabeth Parrish is a globally recognized biotech innovator, humanitarian, and CEO of BioViva Sciences, a leading gene therapy company advancing the reversal of biological aging and age-related diseases. She is best known for becoming the first person in history to undergo experimental gene therapy to reverse aging, demonstrating her personal commitment to pushing the boundaries of science.
Liz leads BioViva's development of combinatorial gene therapies using its proprietary CMV delivery platform, with a mission to extend healthy human lifespan. She is also a vocal advocate for the Best Choice Medicine framework—a progressive regulatory model designed to accelerate access to transformative genetic treatments.
As a founding member of the International Longevity Alliance and affiliated with the Complex Biological Systems Alliance, Liz combines advocacy, investment, and science through initiatives like BioTrove Investments and the BioTrove Podcast. A frequent speaker at TEDx, WIRED, and major biotech forums, she is a leading voice in the movement to treat aging as a disease—and a visionary partner in the Immortalis mission to save lives and shape the future of medicine.
Founder & CEO, Sierra Sciences | World Leader in Telomere Biology & Lifespan Extension
Dr. Bill Andrews is a pioneering molecular biologist, inventor, and longevity researcher best known for his groundbreaking work on telomeres—the protective caps on our chromosomes that act as a biological clock of aging. As Founder and CEO of Sierra Sciences, Dr. Andrews has spent decades developing therapeutic solutions to lengthen telomeres and extend human healthspan and lifespan.
In the 1990s, while at Geron Corporation, he led the team that discovered both the RNA and protein components of telomerase, the enzyme responsible for preventing telomere shortening—an achievement that reshaped the field of aging research. Today, his company continues to develop telomerase-based therapies aimed at reversing age-related decline in humans.
Dr. Andrews holds over 50 U.S. patents on telomerase and has been featured in Popular Science, The Today Show, and the award-winning documentary The Immortalists, which he co-starred in alongside Dr. Aubrey de Grey. A recipient of the National Inventor of the Year award (2nd place, 1997), he also holds a Ph.D. in Molecular and Population Genetics from the University of Georgia.
In addition to his scientific achievements, Dr. Andrews is a world-class ultramarathon runner, often competing in 100+ mile races in extreme environments. His personal quest to cure aging is both professional and personal—and his visionary partnership with Immortalis reflects his belief that telomere shortening is the ultimate barrier to human longevity—and it can be overcome.
Neuroscientist & ARPA-H Program Manager | Pioneer in Brain Tissue Regeneration & Longevity Technologies
Dr. Jean Hébert is a leading neuroscientist, geneticist, and translational innovator focused on reversing brain aging and replacing damaged brain tissue to radically extend human cognitive health and lifespan. His career has been defined by a singular mission: to accelerate the use of cutting-edge technologies to replace, regenerate, and restore the human body—starting with the brain.
Dr. Hébert earned his Ph.D. in Genetics from UCSF, where he studied embryonic stem cell differentiation, followed by postdoctoral research at Stanford on how neural stem cells generate the neocortex—the seat of higher cognition. He later served as a Professor of Neuroscience and Genetics at Albert Einstein College of Medicine, leading a lab focused on reversing brain aging through tissue-based approaches.
To fast-track this vision to clinical reality, Dr. Hébert founded a biotech company developing functional neocortical tissue replacement and now serves as a Program Manager at ARPA-H, where he advances some of the U.S. government's most ambitious projects in brain regeneration and human longevity. He is a personal supporter of the Immortalis mission to cure aging and expand the frontiers of human potential.
Executive Director, Regenerative Medicine Foundation | Global Advocate for Ethical Biotech & Patient-Centered Innovation
Bernard Siegel is a visionary attorney, advocate, and international leader in regenerative medicine policy and public engagement. As the Founder and Executive Director of the Regenerative Medicine Foundation and the Healthspan Action Coalition, he has spent over two decades building the global infrastructure for ethical, patient-driven advancement in stem cell and longevity science.
Best known for filing the landmark legal case that exposed the world’s first alleged human cloning hoax, Siegel pivoted from a 30-year legal career to become one of the most influential voices in biotech advocacy. He founded and co-chaired 20+ World Stem Cell Summits, initiated groundbreaking dialogues at the United Nations, and helped lead campaigns that protected critical research from global bans.
Siegel has advised, convened, and mobilized over 100 international organizations and served on high-impact boards such as Alliance for Regenerative Medicine, Coalition for the Advancement of Medical Research, and California’s Proposition 14 ($5.5B stem cell funding initiative). He has spoken at the Vatican, the White House, and the World Congress on Freedom of Scientific Research, and appeared on major media outlets including CNN, CBS, NPR, and Fox News.
A lifelong defender of scientific freedom and patient access, Siegel continues to shape global policy and collaboration around regenerative medicine—and stands as a powerful ally in the Immortalis mission to accelerate cures and expand healthy human lifespan.
Join | Community | Support | Shop Immortalis